Postoperative Inflammation

• FDA approval · 2026-01-26
  FDA Approved: DIFLUPREDNATE — Original Application (Alembic Pharmaceuticals Inc.)

  FDA approved Alembic Pharmaceuticals' difluprednate ophthalmic emulsion 0.05% as a generic version for treating inflammation of the eye and …

• FDA approval · 2025-02-11
  FDA Approved: DIFLUPREDNATE — Original Application (Upsher-Smith Laboratories, LLC)

  FDA approved the original application for difluprednate from Upsher-Smith Laboratories, enabling a generic ophthalmic corticosteroid for pos…

• FDA approval · 2025-01-28
  FDA Approved: LOTEPREDNOL ETABONATE — Supplemental Application (ARMAS PHARMACEUTICALS INC.)

  FDA approves a supplemental application for Loteprednol Etabonate from Armas Pharmaceuticals Inc. under ANDA 212080, finalizing the status o…

• FDA approval · 2012-10-16
  FDA Approved: ILEVRO — Original Application (Novartis Pharmaceuticals Corporation)

  FDA approved ILEVRO (nepafenac) from Novartis Pharmaceuticals Corporation as the original application for reducing postoperative pain and in…

• FDA approval · 2008-05-08
  FDA Approved: NEVANAC — Supplemental Application (Harrow Eye, LLC)

  FDA approved a supplemental application for NEVANAC (nepafenac) from Harrow Eye, LLC.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.